Xiayang Qiu, Regor Therapeutics CEO
March 23, 2022 02:04 PM EDT
Pharma

Ex-Pfiz­er staffers slap back at ac­cu­sa­tions they stole trade se­crets for new Eli Lil­ly part­ner

Paul Schloesser

Associate Editor

Al­most two months af­ter Pfiz­er sued small biotech Re­gor Ther­a­peu­tics and its top ex­ecs over al­le­ga­tions they stole com­pa­ny se­crets, the co-founders re­spond­ed to the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times